Current practices and safety of medication use during rapid sequence intubation
Journal of Critical Care May 25, 2018
Groth CM, et al. - In this multicenter, observational, cross-sectional study, researchers analyzed current practices and safety of medication use during rapid sequence intubation (RSI) in adult and pediatric intensive care unit and emergency department patients. Findings revealed significant differences in medication use by provider type and medications were often used inappropriately. Administration of etomidate to 58% with sepsis was reported, with no observed association with adrenal insufficiency. Ketamine was found to be associated with hypotension post-RSI and use was low with traumatic brain injury/stroke. The presence of an opportunity for optimization of medication use during RSI was realized.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries